Chronic Disease AI Platform Motivia Raises $1.2M
alejandroll10 · x · 2026-07-17
Motivia, a company building an AI platform for chronic disease adherence, recently closed a $1.2 million funding round.
Business updates mentioned in the post include:
- After its heart failure pilot project partnered with insurer OMINT, rehospitalization rates dropped by 87% and mortality rates fell by 44%.
- The platform uses risk prediction and behavioral reminders to help patients stick to their treatment plans between visits.
- The product can read data from Medtronic devices for remote alerts; Medtronic is a strategic regional partner.
- Astellas uses its remote monitoring workflow for prostate cancer in Mexico, and IQVIA Mexico is also participating in data collaboration.
- The consumer app is now live with over 2,000 monthly active users, and it was a finalist at South Summit Brazil.
More from Venture
- Presidio acquires LookingPoint to expand AI, cloud and cybersecurity — TechNadu · 2026-07-21
- AI bottlenecks are shifting to memory, optics, yield control and power — thedealdirector · 2026-07-21
- A solo builder’s AI horse-racing app lands its first $29 monthly customer in two weeks — Embarrassed_Belt3438 · 2026-07-21
- Frontier models improve on earnings-direction benchmarks, but open models still lag — dougclinton · 2026-07-21
- How a 3-person AI dating app hit $120K a month, and how a non-coder made money with AI — huangyun_122 · 2026-07-21
- Bullish AI-stock thesis says Tesla robotaxis could reach $50B EBIT at scale — JOBhakdi · 2026-07-21